Inflammation is a balanced physiological response – the body needs it to eliminate invasive organisms and foreign irritants, but excessive inflammation can harm healthy cells, contributing to aging and chronic diseases. To help keep tabs on inflammation, immune cells employ a molecular machine called the NLRP3 inflammasome. NLRP3 is inactive in a healthy cell, but is switched “on” when the cell’s mitochondria (energy-generating organelles) are damaged by stress or exposure to bacterial toxins.
However, when the NLRP3 inflammasome gets stuck in the “on” position, it can contribute to a number of chronic inflammatory conditions, including gout, osteoarthritis, fatty liver disease and Alzheimer’s and Parkinson’s diseases. In a new mouse study, researchers at University of California San Diego School of Medicine discovered a unique approach that might help treat some chronic inflammatory diseases: force cells to eliminate damaged mitochondria before they activate the NLRP3 inflammasome.
The study, published April 11, 2019 by Cell Metabolism, was led by senior author Michael Karin, PhD, Distinguished Professor of Pharmacology and Pathology and Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases at UC San Diego School of Medicine, and first author Elsa Sanchez-Lopez, PhD, a senior postdoctoral researcher in Karin’s lab.
In a 2018 study published in Nature, Karin’s team had shown that damaged mitochondria activate the NLRP3 inflammasome. The researchers also found that the NLRP3 inflammasome is de-activated when mitochondria are removed by the cell’s internal waste recycling process, called mitophagy.
“After that, we wondered if we could reduce harmful excess inflammation by intentionally inducing mitophagy, which would eliminate damaged mitochondria and should in turn pre-emptively inhibit NLRP3 inflammasome activation,” Karin said. “But at the time we didn’t have a good way to induce mitophagy.”
More recently, Sanchez-Lopez was studying how macrophages regulate their uptake of choline, a nutrient critical for metabolism, when she discovered something that can initiate mitophagy: an inhibitor of the enzyme choline kinase (ChoK). With ChoK inhibited, choline is no longer incorporated into mitochondrial membranes. As a result, the cells perceive the mitochondria as damaged, and cleared them away by mitophagy.
“Most importantly, by getting rid of damaged mitochondria with ChoK inhibitors, we were finally able to inhibit NLRP3 inflammasome activation,” Karin said.
To test their new ability to control NLRP3 inflammasome in a living system, the researchers turned to mice. They discovered that treatment with ChoK inhibitors prevented acute inflammation caused by uric acid (accumulation of which triggers gout flares) and a bacterial toxin.
By several measures, ChoK inhibitor treatment also reversed chronic inflammation associated with a genetic disease called Muckle-Well Syndrome, which is caused by mutations in NLRP3 genes. One such measure is spleen size – the larger the spleen, the more inflammation. The spleens of Muckle-Well Syndrome mice are on average twice as large as normal mice, but their spleen sizes normalized after ChoK inhibitor treatment.
NLRP3 inflammasome promotes inflammation because it triggers the release of two very potent pro-inflammatory molecules called cytokines: interleukin (IL)-1? and IL-18. According to Karin, there are existing drugs that can block IL-1?, but not IL-18. ChoK inhibitors, his team found, can reduce both cytokines.
“There are several diseases, including lupus and osteoarthritis, whose treatment will likely require dual inhibition of both IL-1? and IL-18,” Karin said.
The Latest on: Chronic inflammatory disease
via Google News
The Latest on: Chronic inflammatory disease
- Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptomson April 13, 2021 at 9:30 am
Of the 36 questionnaires of controls, 1 was incomplete, 2 were excluded respectively because of history of inflammatory bowel disease and chronic treatment by glucocorticoid for asthma. Flow chart for ...
- EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseaseson April 13, 2021 at 3:00 am
EpiEndo Pharma Announces First-in-Human Clinical Trial of EpiEndo’s Lead Compound, EP395, for Chronic Inflammatory Airway Diseases ...
- What to Know About Telehealth for Crohn's Diseaseon April 12, 2021 at 9:26 am
Telehealth for chronic conditions such as Crohn's disease has become ... it's truly exciting because it can offer people who live with Crohn's disease more access to inflammatory bowel disease (IBD) ...
- UK Inflammatory Bowel Disease (IBD) Market Share 2019: Trends, Key Players, Industry Analysis and Report 2019-2025on April 12, 2021 at 2:28 am
IBD is one of the key chronic inflammatory digestive diseases prevalent in the country. The disease is caused by a number of factors including the changing lifestyle of the population, the prevalence ...
- Chronic sinus inflammation linked to altered brain activityon April 11, 2021 at 6:02 pm
More than one in 10 adults in the United States suffer from chronic rhinosinusitis, a persistent inflammatory sinus ... problems often linked to the disease. “We know from previous studies ...
- Study on chronic sinus diseaseon April 10, 2021 at 11:21 am
Or we could look for inflammatory molecules or ... people who have been clinically diagnosed with chronic sinusitis. It might involve scanning patients' brains, then providing typical treatment for ...
- Anti-Inflammatory Meal Plan for Beginnerson April 8, 2021 at 11:38 am
The goal of this healthy diet is to reduce chronic inflammation in our body, which is linked to conditions like heart disease, diabetes and even some cancers. The anti-inflammatory diet is very ...
- Lyfebulb and Arena Pharmaceuticals Seek Applicants for the 2021 Imagining Life Without Limits - An Inflammatory Bowel Disease Innovation Challengeon April 8, 2021 at 5:55 am
Announcing the 2021 "Imagining Life Without Limits - An Inflammatory Bowel Disease ... solutions to combat the burdens afflicted by chronic disease," said Dr. Karin Hehenberger, CEO and Founder ...
- Can diet help with inflammatory bowel disease?on April 7, 2021 at 1:11 pm
More than 6.8 million people worldwide are estimated to be living with inflammatory bowel disease (IBD). IBD is believed to be the result of a malfunctioning immune system, which results in an ...
- How peptic ulcer disease could potentially lead to the lifelong, debilitating effects of chronic fatigue syndrome: an insighton April 6, 2021 at 11:24 am
Chronic Fatigue Syndrome (CFS) has been defined as unexplained relapsing or persistent fatigue for at least 6 consecutive months. Immuno-inflammatory pathway, bacterial infection, and other causes ...
via Bing News